BioSpace News Archive

Nunzia Pharmaceutical Launches its Breakthrough NUNZIA Nutraceutical and Pharma Treatment for Autism Spectrum and Other Anxiety Disorders

Parata Systems launched the Pharmacy Employee Relief Fund with an initial commitment of $100,000.

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, is pleased to announce that the United States Federal Food and Drug Agency (“FDA”) has approved a supplemental Investigational Device Exemption (“IDE”) for the use of Spectral’s PMX cartridge (“PMX”) in the treatment of patients with COVID-19.

Antengene announced today that it has dosed the first patient in Taiwan , China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and tolerability of ATG-019 monotherapy or ATG-019 combined with niacin ER (vita

Nelson to lead business development efforts to educate and inform medical device companies on new product offerings for growing hydrophilic coating provider.

Impulse Dynamics, a medical device company dedicated to improving the lives of heart failure patients, today announced the publication of the FIX-HF-5C2 study in Circulation: Heart Failure.

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Shahe Garabedian as Senior Vice President of Quality Assurance and the issuance of an inducement award.

Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets has appointed seasoned medical device sales executive Jeff Weinrich to its Board of Directors

Lumiata uses artificial intelligence to address the cost and risk of healthcare for customers.